{"nctId":"NCT02637427","briefTitle":"Does Plasma Reduce Bleeding in Patients Undergoing Invasive Procedures","startDateStruct":{"date":"2016-02-26","type":"ACTUAL"},"conditions":["Blood Coagulation Disorders","Hemorrhage"],"count":57,"armGroups":[{"label":"Fresh frozen plasma transfusion","type":"EXPERIMENTAL","interventionNames":["Biological: Fresh frozen plasma transfusion"]},{"label":"No transfusion","type":"NO_INTERVENTION","interventionNames":[]}],"interventions":[{"name":"Fresh frozen plasma transfusion","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. INR level between 1.50 and 2.50 inclusive\n2. undergoing an invasive procedure at the bedside, endoscopy laboratory, or in radiology\n\nExclusion Criteria:\n\n1. undergoing a surgical procedure in the operating room;\n2. active bleeding;\n3. undergoing a procedure involving or proximal to the central nervous system or spinal cord;\n4. cardiac catheterization,\n5. using 4 factor plasma concentrates\n6. using systemic heparin/heparinoid therapy, direct factor X inhibitors and other anticoagulants for which plasma will not correct prolonged INR;\n7. platelet count less than 50,000/ul,\n8. congenital coagulation disorders;\n9. acquired disorders (i.e., lupus anticoagulant) for which plasma will not correct the disorder;\n10. women who are pregnant and;\n11. unwillingness to consider blood transfusion.","healthyVolunteers":false,"sex":"ALL","minimumAge":"21 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Hemoglobin Level","description":"Change from pre-procedure hemoglobin to lowest within 2 days after procedure","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.6","spread":"1.0"},{"groupId":"OG001","value":"-0.4","spread":"0.6"}]}]}]},{"type":"SECONDARY","title":"Number of Red Blood Cell Transfusions","description":"Differences in number of units of red blood cell transfusions between the two study arms","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Transfusion Associated Cardiac Overload (TACO)","description":"Difference in rates between the two study arms","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Transfusion Related Acute Lung Injury (TRALI).","description":"Difference in rates between the two study arms","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Major Bleed","description":"2g/dL or greater fall in hemoglobin level","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in International Normalized Ratio (INR) Level Post Procedure","description":"Change from pre-procedure INR level","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.24","spread":"0.26"},{"groupId":"OG001","value":"0","spread":"0.15"}]}]}]},{"type":"SECONDARY","title":"Change in INR Level Day 1","description":"Change from pre-procedure INR level","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.22","spread":"0.19"},{"groupId":"OG001","value":"-0.03","spread":"0.19"}]}]}]},{"type":"SECONDARY","title":"Change in INR Level Day 2","description":"Change from pre-procedure INR level","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.09","spread":"0.39"},{"groupId":"OG001","value":"0","spread":"0.19"}]}]}]},{"type":"SECONDARY","title":"Mortality (Number of Participants)","description":"Death","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Infection","description":"Pneumonia or blood stream infection","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With ICU Admission","description":"new admission to the intensive care unit","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":2,"n":27},"commonTop":[]}}}